Atom Investors LP raised its holdings in IDEX Co. (NYSE:IEX - Free Report) by 5.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 48,196 shares of the industrial products company's stock after buying an additional 2,446 shares during the period. IDEX comprises about 1.1% of Atom Investors LP's holdings, making the stock its 7th largest position. Atom Investors LP owned approximately 0.06% of IDEX worth $10,338,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in IEX. Studio Investment Management LLC grew its stake in shares of IDEX by 4.9% in the 3rd quarter. Studio Investment Management LLC now owns 955 shares of the industrial products company's stock worth $205,000 after acquiring an additional 45 shares in the last quarter. UMB Bank n.a. increased its stake in IDEX by 31.0% in the 2nd quarter. UMB Bank n.a. now owns 241 shares of the industrial products company's stock valued at $48,000 after buying an additional 57 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of IDEX by 19.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 344 shares of the industrial products company's stock worth $72,000 after buying an additional 57 shares in the last quarter. Whittier Trust Co. grew its holdings in shares of IDEX by 38.4% in the second quarter. Whittier Trust Co. now owns 209 shares of the industrial products company's stock valued at $42,000 after acquiring an additional 58 shares in the last quarter. Finally, Catalyst Capital Advisors LLC increased its position in shares of IDEX by 73.8% during the third quarter. Catalyst Capital Advisors LLC now owns 139 shares of the industrial products company's stock valued at $30,000 after acquiring an additional 59 shares during the last quarter. Institutional investors and hedge funds own 97.96% of the company's stock.
IDEX Price Performance
IEX traded up $1.12 on Monday, reaching $231.75. The company had a trading volume of 360,893 shares, compared to its average volume of 481,801. The company has a debt-to-equity ratio of 0.54, a quick ratio of 2.11 and a current ratio of 2.97. IDEX Co. has a 52-week low of $189.51 and a 52-week high of $246.36. The company has a market cap of $17.55 billion, a price-to-earnings ratio of 35.61, a P/E/G ratio of 2.44 and a beta of 0.96. The business has a 50 day simple moving average of $217.66 and a 200 day simple moving average of $208.03.
IDEX (NYSE:IEX - Get Free Report) last released its earnings results on Tuesday, October 29th. The industrial products company reported $1.90 EPS for the quarter, beating analysts' consensus estimates of $1.89 by $0.01. IDEX had a return on equity of 15.92% and a net margin of 15.35%. The business had revenue of $798.20 million for the quarter, compared to analysts' expectations of $793.05 million. During the same quarter in the prior year, the firm earned $2.12 earnings per share. The firm's revenue was up .6% on a year-over-year basis. As a group, sell-side analysts anticipate that IDEX Co. will post 7.89 EPS for the current year.
IDEX Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, January 17th will be given a dividend of $0.69 per share. This represents a $2.76 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date of this dividend is Friday, January 17th. IDEX's payout ratio is currently 42.72%.
Analyst Ratings Changes
Several equities research analysts have recently issued reports on IEX shares. Argus lowered IDEX from a "buy" rating to a "hold" rating in a research report on Wednesday, August 14th. Stifel Nicolaus lifted their price objective on shares of IDEX from $232.00 to $244.00 and gave the stock a "buy" rating in a research report on Wednesday, October 16th. DA Davidson dropped their target price on shares of IDEX from $220.00 to $210.00 and set a "neutral" rating on the stock in a research note on Monday, August 5th. TD Cowen decreased their price target on shares of IDEX from $240.00 to $230.00 and set a "buy" rating for the company in a research note on Wednesday, August 7th. Finally, Robert W. Baird reduced their price objective on IDEX from $245.00 to $241.00 and set an "outperform" rating for the company in a report on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $241.14.
View Our Latest Report on IDEX
IDEX Company Profile
(
Free Report)
IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.
See Also
Before you consider IDEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEX wasn't on the list.
While IDEX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.